Transfer is not included
Centro Médico Teknon is a private medical facility in Barcelona, Spain offering world-class care in specialties such as epileptology, neurosurgery, oncology, heart surgery, and stem cell therapy. Dr. Jon Karles Galseran, an onco-urologist with experience since 1987, offers a targeted therapy procedure in Spain, which includes a complete blood count with cancer markers and a proteinogram. This procedure does not include accommodation or transfer and requires a one-day stay in the hotel. Patients from all over the world can find top-notch care for various medical needs, ranging from online consultations to complex surgeries.
Centro Médico Teknon is the No.1 choice for celebrities, sportsmen, and politicians. Their team of highly qualified doctors and medical coordinators works together to ensure the highest quality of care and patient satisfaction. To find out more about the clinic and Dr. Galseran and book the Targeted therapy in Spain offered by the clinic and Dr. Jon Karles Galseran, visit the Bookimed website.
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with installment options.
Earn rewards for referring friends to Bookimed.
Targeted therapy (targeted therapy, molecular targeted therapy, molecular targeted therapy) is a medical treatment of cancer using drugs that act specifically on cancer cells and do not harm healthy tissues.
Doctors may prescribe it as the main method of treatment or in combination with other procedures - surgery, radiation and chemotherapy.
The principle of operation of a targeted drug depends on its type. The American Cancer Society identifies the following goals for targeted therapy:
Depending on the active substance that is part of the drug, the Canadian Cancer Society distinguishes the following types of molecular targeted therapy:
When entering the body, monoclonal antibodies find cancer cells, attach to the shell and trigger a self-destruction mechanism in them.
Monoclonal antibodies also increase the effectiveness of chemotherapy and radiation therapy - they help chemotherapy drugs and radiation to penetrate into the cancer cell and destroy it.
The names of all drugs containing monoclonal antibodies end in “mab” (for example, Pembrolizumab, Trastuzumab, Rituximab, etc.).
Interesting to know:
Monoclonal antibodies are also used in immunotherapy, because they activate the immune system and it begins to destroy the tumor on its own.
Tyrosine kinase inhibitors block the signaling of a cancer cell that causes it to grow.
The name of such drugs ends with “nib” (Imatinib, Gefitinib, etc.)
Such drugs activate signals in cancer cells that cause them to die.
Apoptosis-inducing drugs include Oblimersen, Bortezomib, Olaparib.
They prevent the development of new blood vessels that feed the tumor.
Angiogenesis inhibitors include Sunitinib, Bevacizumab, and Thalidomide.
The substance blocks a protein that is responsible for the growth and division of cancer cells.
Medications based on mTOR inhibitors - Everolimus, Temsirolimus.
Hormone therapy is a subspecies of targeted therapy. It prevents hormones (estrogen, testosterone, and progesterone) from binding to receptors that help cancer cells grow. Due to this, the tumor dies.
To select a targeted therapy drug and determine the duration of treatment, the doctor prescribes an immunohistochemical study - an analysis of tumor tissue obtained by biopsy. It allows you to determine the type of cancer cells and identify genetic mutations and proteins that are targets for targeted drugs.
If the patient has already taken the material, it is necessary to bring blocks and glasses with you to the clinic. Doctors will review them and the procedure will not have to be repeated.
A unique test to select the most effective drug
The FoundationOne tumor test is available at the Ichilov and Assuta Clinic (Israel) and the Anadolu Medical Center (Turkey). It allows you to determine which target drug the tumor is most sensitive to. This test requires special laboratory equipment and doctor's qualifications, therefore it is available only in some clinics around the world.
Targeted therapy is inpatient or outpatient, depending on the general condition of the patient and the need for additional treatment. At the same time, it is not necessary to stay in the country in which you were selected and prescribed the drug. You can buy medicine, return home and take it according to the prescribed regimen in your place of residence.
The duration of 1 course of targeted therapy is individual. On average, it is 2 weeks. The doctor determines the number of courses individually for each patient. This is influenced by the diagnosis, general health, disease and body response to drugs.
Because targeted drugs target cancer cells, this treatment is easier than chemotherapy. However, there is a risk of certain complications. The American Cancer Society lists them as:
The price of targeted therapy depends on:
In our catalog, in the cards of clinics, the price is indicated for 1 course of treatment with targeted drugs. The required number of courses is determined by the attending physician based on the diagnostic results. Therefore, you can find out the final cost of targeted therapy after the doctor gets acquainted with the diagnosis and the results of the examination.
Leave a request on our website, and a Bookimed coordinating doctor will contact you at a convenient time for you. He will talk about the features of the technique, orient on the cost. Together with the coordinating doctor, you will select the best medical center for your case.
Our care department will help you arrange your travel for treatment and will stay in touch with you from the moment you contact us and even after you return home.
You do not pay for Bookimed services.